section name header

Pronunciation ⬇

GLYE-koe-pir-OH-nee-um

Classifications ⬆ ⬇

Therapeutic Classification: none assigned

Pharmacologic Classification: anticholinergics

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits the action of acetylcholine at receptors on certain peripheral tissues, including sweat glands, which reduces sweating.
Therapeutic effects:
  • Reduced sweating.

Pharmacokinetics ⬆ ⬇

Absorption: Not systemically absorbed after topical administration.

Distribution: Minimal to no distribution to tissues.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(plasma concentrations)

ROUTEONSETPEAKDURATION
Topicalunknownunknownunknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: burning, erythema, dry skin, pruritus

EENT: blurred vision, dry eye, mydriasis, nasal dryness, oropharyngeal pain

GI: dry mouth, constipation

GU: urinary hesitation, urinary retention

Neuro: headache

Misc: fever, heat stroke

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Qbrexza